Screener
Eligibility screening
NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC
17 US sites in CA, CO, DC, FL +10
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.
Screener
NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC
17 US sites in CA, CO, DC, FL +10
Before we begin
Your answer affects how the questions are phrased.